With ISCRM fellowship funding, Willow Chernoske will develop and conduct a proof of concept for a CRISPR-Cas12a biotinylation system designed by the Escobar Lab to determine the epigenetic mechanisms that maintain the poised chromatin state of memory CD8+ T cells. The goal is to produce insights relevant to the fields of immunology and chromatin biology.